薬物スクリーニングの世界市場レポート 2025年

薬物スクリーニングの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR15.0％で171億米ドルに成長します。予測期間の成長は、大麻の合法化とオピオイド危機、スポーツイベントの増加、ポイントオブケアと迅速検査、薬物政策と規制の進化、職場のウェルネスと健康プログラムの拡大、国際市場の拡大に起因すると考えられます。予測期間における主な動向としては、高度な薬物検出技術、遠隔医療・遠隔検査、研究開発投資、革新的な薬物検査キット・機器、検査技術の進歩などが挙げられます。

薬物スクリーニング市場の成長は、薬物およびアルコールの消費量の増加によって牽引されると予想されます。薬物中毒は、脳と行動の両方に影響を及ぼす病態であり、アルコール、マリファナ、ニコチンなどの合法または違法な物質の使用を制御できなくなります。薬物中毒やアルコール中毒が増加するにつれて、関連する健康リスクも増加し、薬物スクリーニングの需要が必要となります。2022年、薬物とアルコールの消費に関する世界の懸念は根強く、全米薬物使用・健康調査（NSDUH）は、12歳以上のアメリカ人の薬物使用が前年比3.8％増加したと報告しています。また、同年齢層の21.4％が過去1年間に違法薬物を使用したり、処方箋薬を誤用した経験があることも報告されました。現在進行中のパンデミックは薬物リスクをさらに悪化させ、若者の大麻摂取量は特定の地域で4倍にも増加しました。薬物とアルコールの消費量の増加は、薬物スクリーニング市場の成長に大きく寄与しています。

薬物乱用治療に対する需要の高まりが、今後の薬物スクリーニング市場の成長を牽引すると予想されます。物質乱用とは、使用者や他人に悪影響を及ぼす量の有害な物質の使用を指します。薬物スクリーニングは、通常体内に存在しない化合物を特定するのに役立ちます。このプロセスはスクリーニング検査から始まり、その後に特定の物質を検出・確認するための二次検査が行われるため、薬物乱用治療に対する需要の高まりが市場の拡大を支えることになります。例えば、2023年8月に米国保健社会福祉省が発表した報告書によると、米国では2,700万人以上が最近違法薬物の使用や処方薬の誤用を報告しました。さらに、成人と青少年のほぼ4分の1が、過去1ヵ月間に暴飲暴食をしたことを認めています。薬物乱用の年間経済コストは、アルコールで2,490億米ドル、違法薬物で1,930億米ドルと推定されています。したがって、薬物乱用治療に対するニーズの高まりが、予測期間中の薬物スクリーニング市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の薬物スクリーニング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の薬物スクリーニング市場成長率分析
• 世界の薬物スクリーニング市場の実績：規模と成長, 2019-2024
• 世界の薬物スクリーニング市場の予測：規模と成長, 2024-2029, 2034F
• 世界の薬物スクリーニング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の薬物スクリーニング市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 迅速検査装置
• 消耗品
• その他の製品
• 世界の薬物スクリーニング市場：サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 口腔液サンプル
• 毛髪サンプル
• 尿サンプル
• 呼気サンプル
• その他のサンプルタイプ
• 世界の薬物スクリーニング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物検査研究所
• 職場
• 刑事司法および法執行機関
• 病院
• 薬物治療センター
• 個人ユーザー
• 疼痛管理センター
• 学校と大学
• 世界の薬物スクリーニング市場：迅速検査装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 尿薬物検査キット
• 唾液薬物検査キット
• 血液薬物検査装置
• インスタントテストストリップ
• 世界の薬物スクリーニング市場：消耗品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬とアッセイ
• サンプル収集装置
• 校正標準
• 世界の薬物スクリーニング市場：その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 実験装置
• ソフトウェアソリューション
• 保管および輸送ソリューション

第7章 地域別・国別分析

• 世界の薬物スクリーニング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の薬物スクリーニング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 薬物スクリーニング市場：競合情勢
• 薬物スクリーニング市場：企業プロファイル
  • Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• Dragerwerk AG & Co. KGaA
• LifeLoc Technologies Inc.
• MPD Inc.
• Omega Laboratories Inc.
• Premier Biotech Inc.
• Psychemedics Corporation
• F. Hoffmann-La Roche Ltd.
• Shimadzu Corporation
• Siemens Healthineers AG
• Medtox Scientific Inc.
• American Screening Corporation
• Clinical Reference Laboratory Inc.
• Express Diagnostics International Inc.
• Global Drug Testing Services

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 薬物スクリーニング市場2029年-最も新しい機会を提供する国
• 薬物スクリーニング市場2029年-最も新しい機会を提供するセグメント
• 薬物スクリーニング市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $8.57 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to pharmaceutical drug testing, healthcare and clinical diagnostics, substance abuse treatment, research and development investments, and increasing use of drug testing kits and devices.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $17.1 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to legalization of cannabis and opioid crisis, increasing sports events, point-of-care and rapid testing, evolving drug policies and regulations, growing workplace wellness and health programs, and international market expansion. Major trends in the forecast period include advanced drug detection technologies, telemedicine and remote testing, research and development investments, innovative drug testing kits and devices, and technological advancements in testing.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. In 2022, global concerns about drug and alcohol consumption persisted, with the National Survey on Drug Use and Health (NSDUH) reporting a 3.8% year-over-year increase in drug use among Americans aged 12 and over. The report also highlighted that 21.4% of people in the same age group had used illegal drugs or misused prescription drugs in the past year. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

The increasing demand for substance abuse treatment is expected to drive the growth of the drug screening market in the future. Substance abuse refers to the harmful use of a substance in quantities that negatively affect the user or others. Drug screening helps identify compounds that are typically not present in the body. The process begins with a screening test, which is followed by a secondary test to detect and/or confirm the presence of specific substances, so the growing demand for drug abuse treatment will support market expansion. For example, in August 2023, a report from the U.S. Department of Health and Human Services indicated that over 27 million people in the United States had recently reported using illicit drugs or misusing prescription medications. Furthermore, nearly a quarter of both adults and adolescents admitted to binge drinking in the past month. The annual economic cost of substance misuse is estimated at $249 billion for alcohol and $193 billion for illicit drugs. Therefore, the rising need for substance abuse treatment is propelling the growth of the drug screening market during the forecast period.

A notable trend in the drug screening market is the launch of innovative products. Major companies in this sector are actively developing and introducing innovative products to meet the rapidly growing industry demand and enhance their market positions. The COVID-19 pandemic prompted a shift in drug screening approaches, fostering innovation and new product development. Companies are striving to create more effective and widely applicable drug tests for laboratory use. For example, in September 2022, Sysmex Corporation, a Japan-based healthcare company, launched the UF-1500 Fully Automated Urine Particle Testing Analyzer. This innovative product, designed for urine sediment testing and screening, inherits the functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer while achieving a downsizing of the former model, exemplifying the trend of innovative product launches in the drug screening market.

Companies in the drug screening market are increasingly turning their attention to strategic partnerships and collaborations as a means to enhance their financial strength, fortify their product portfolios, and extend their geographical reach. Strategic collaborations involve agreements between two or more parties to jointly pursue agreed-upon objectives while maintaining their independence as organizations. An illustrative example occurred in December 2022 when PhoreMost Ltd., a UK-based biopharmaceutical company, and ThinkCyte K.K., a Japan-based biotechnology company, announced a strategic research partnership focused on advancing modern phenotypic drug screening through the application of artificial intelligence (AI). This collaboration integrates PhoreMost's SITESEEKER platform, designed to identify optimal new targets for future therapies, with ThinkCyte's Ghost Cytometry technology-a platform leveraging AI for cell characterization and sorting. By combining these innovative technologies, the partnership aims to improve the efficiency and effectiveness of phenotypic drug screening. The collaboration has the potential to identify novel drug targets and facilitate the development of effective therapeutics by leveraging AI and machine learning.

In April 2022, Saladax Biomedical, Inc., a US-based company specializing in the development, manufacturing, and marketing of assays providing rapid therapeutic drug levels, acquired a patent portfolio for antipsychotic drug testing and screening from Janssen Pharmaceutica NV, a Belgium-based pharmaceutical company. This acquisition enabled Saladax to develop tests compatible with chemistry analyzers commonly found in hospitals and a point-of-care instrument suitable for settings where centralized testing is not feasible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by delivering rapid and actionable results to healthcare professionals. The collaboration exemplifies how strategic acquisitions contribute to addressing clinical needs and expanding the offerings in the drug screening market.

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Products: Rapid Testing Devices; Consumables; Other Products
• 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
• 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
• Subsegments:
• 1) By Rapid Testing Devices: Urine Drug Test Kits; Saliva Drug Test Kits; Blood Drug Test Devices; Instant Test Strips
• 2) By Consumables: Reagents and Assays; Sample Collection Devices; Calibration Standards
• 3) By Other Products: Laboratory Equipment; Software Solutions; Storage and Transport Solutions
• Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; OraSure Technologies Inc.; Alfa Scientific Designs Inc.; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Screening Market Characteristics

3. Drug Screening Market Trends And Strategies

4. Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drug Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Screening Market Growth Rate Analysis
• 5.4. Global Drug Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Screening Total Addressable Market (TAM)

6. Drug Screening Market Segmentation

• 6.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Testing Devices
• Consumables
• Other Products
• 6.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Fluid Sample
• Hair Sample
• Urine Sample
• Breath Sample
• Other Sample Types
• 6.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Testing Laboratories
• Workplaces
• Criminal Justice and Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools and Colleges
• 6.4. Global Drug Screening Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Urine Drug Test Kits
• Saliva Drug Test Kits
• Blood Drug Test Devices
• Instant Test Strips
• 6.5. Global Drug Screening Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents and Assays
• Sample Collection Devices
• Calibration Standards
• 6.6. Global Drug Screening Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Equipment
• Software Solutions
• Storage and Transport Solutions

7. Drug Screening Market Regional And Country Analysis

• 7.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Screening Market

• 8.1. Asia-Pacific Drug Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Screening Market

• 9.1. China Drug Screening Market Overview
• 9.2. China Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Screening Market

• 10.1. India Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Screening Market

• 11.1. Japan Drug Screening Market Overview
• 11.2. Japan Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Screening Market

• 12.1. Australia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Screening Market

• 13.1. Indonesia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Screening Market

• 14.1. South Korea Drug Screening Market Overview
• 14.2. South Korea Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Screening Market

• 15.1. Western Europe Drug Screening Market Overview
• 15.2. Western Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Screening Market

• 16.1. UK Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Screening Market

• 17.1. Germany Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Screening Market

• 18.1. France Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Screening Market

• 19.1. Italy Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Screening Market

• 20.1. Spain Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Screening Market

• 21.1. Eastern Europe Drug Screening Market Overview
• 21.2. Eastern Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Screening Market

• 22.1. Russia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Screening Market

• 23.1. North America Drug Screening Market Overview
• 23.2. North America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Screening Market

• 24.1. USA Drug Screening Market Overview
• 24.2. USA Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Screening Market

• 25.1. Canada Drug Screening Market Overview
• 25.2. Canada Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Screening Market

• 26.1. South America Drug Screening Market Overview
• 26.2. South America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Screening Market

• 27.1. Brazil Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Screening Market

• 28.1. Middle East Drug Screening Market Overview
• 28.2. Middle East Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Screening Market

• 29.1. Africa Drug Screening Market Overview
• 29.2. Africa Drug Screening Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Screening Market Competitive Landscape And Company Profiles

• 30.1. Drug Screening Market Competitive Landscape
• 30.2. Drug Screening Market Company Profiles
  • 30.2.1. Laboratory Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. OraSure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Alfa Scientific Designs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Drug Screening Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Dragerwerk AG & Co. KGaA
• 31.3. LifeLoc Technologies Inc.
• 31.4. MPD Inc.
• 31.5. Omega Laboratories Inc.
• 31.6. Premier Biotech Inc.
• 31.7. Psychemedics Corporation
• 31.8. F. Hoffmann-La Roche Ltd.
• 31.9. Shimadzu Corporation
• 31.10. Siemens Healthineers AG
• 31.11. Medtox Scientific Inc.
• 31.12. American Screening Corporation
• 31.13. Clinical Reference Laboratory Inc.
• 31.14. Express Diagnostics International Inc.
• 31.15. Global Drug Testing Services

32. Global Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Screening Market

34. Recent Developments In The Drug Screening Market

35. Drug Screening Market High Potential Countries, Segments and Strategies

• 35.1 Drug Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer